Al Hikma FZCO markets and promotes health products in the Middle East, Asia, Africa, Europe, Canada and Australia through a qualified team of pharmacists and doctors, and distributes through a large ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Hikma will continue producing its 8 mg naloxone HCl nasal spray in its Columbus, Ohio manufacturing facility and will provide it to Emergent as its exclusive commercial partner. "We are thrilled ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

First in his series is venture capitalists Hikma Ventures’ managing director ... will unlock invaluable information about a patient’s medical history and behaviour, improving outcomes by ...

Holmes Medical Museum in Foley, Alabama tells the story of Baldwin County's first hospital from 1936 to 1958. Step back in ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(RTTNews) - Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent BioSolutions for the sale of KLOXXADO naloxone HCl nasal ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

1 Day HKMPY -0.46% DJIA 0.52% S&P 500 0.11% Health Care/Life Sciences 0.39% ...